GO:0050733 RS domain binding: Mechanism, Genes

GO:0050733, RS domain binding, is a molecular function term in the Gene Ontology that describes the binding of a protein to an RS domain of another protein. RS domains are characterized by repeated arginine-serine dipeptides and are usually highly phosphorylated; they promote protein-protein interactions and help direct subcellular localization, including nucleocytoplasmic shuttling of individual SR proteins, and they play a role in splicing. Because RS domain binding sits at the interface of RNA processing, nuclear organization, and signal-dependent protein interactions, it is a focal point for researchers studying splicing regulation and nuclear speckle biology. The term is distinct from generic protein binding because it specifies a structurally and functionally defined interaction surface: the RS dipeptide-rich domain. In practice, RS domain binding is often inferred from co-immunoprecipitation, pull-down, or proximity assays using RS-domain baits or prey, and it can be modulated by phosphorylation state. Understanding this function helps explain how SR proteins and SR-related proteins assemble into regulatory complexes and how their interactions are rewired in disease.

In plain terms, RS domain binding means one protein physically attaches to a specific part of another protein that is rich in arginine-serine repeats, called an RS domain. The RS domain is usually heavily phosphorylated, and this modification can change which partners it binds and where the protein goes inside the cell. The Gene Ontology uses GO:0050733 to capture this selective interaction, which is central to splicing regulation and nuclear organization.

RS domain binding is important because it explains how a large class of splicing regulators and nuclear organizers find and hold their partners. RS domains are not passive linkers; their phosphorylation state and repeat composition influence interaction specificity, localization, and condensate formation, which in turn affect splicing outcomes and nuclear architecture. When RS domain binding is perturbed, the consequences can include altered splice-site selection, disrupted nuclear speckle organization, and changes in gene expression programs relevant to cancer and other diseases. For researchers, GO:0050733 provides a precise annotation target for experiments that test whether a candidate protein directly engages RS-domain-containing factors, rather than merely co-purifying with them.

The following genes and proteins are directly relevant to RS domain binding, based on their RS-domain content and roles in splicing and nuclear organization.

RS domain binding is regulated primarily through phosphorylation of the RS domain, which is usually highly phosphorylated. Kinases such as CLK and SRPK family members can add phosphates to RS dipeptides, while phosphatases can remove them, thereby altering the interaction surface. This phospho-switch can change which partners bind, where the protein localizes, and whether it shuttles between the nucleus and cytoplasm. In addition, the concentration and phase-separation propensity of RS-domain proteins such as SRRM2 can influence the assembly of nuclear speckle subcompartments, providing a higher-order layer of regulation. Together, these mechanisms allow cells to dynamically tune RS domain binding in response to signaling and metabolic states.

Alterations in RS-domain-containing splicing factors and nuclear speckle components have been linked to cancer-associated splicing changes. Because RS domain binding controls the assembly and localization of splicing regulators, its perturbation can contribute to aberrant splice-site selection and altered gene expression programs in tumors. Targeting RS domain interactions is therefore an area of interest for therapeutic development.

SRRM2 phase separation drives assembly of nuclear speckle subcompartments, and disruption of this process can affect nuclear organization. Since RS domain binding is part of the mechanism that builds these subcompartments, defects in RS domain interactions may contribute to diseases characterized by nuclear speckle abnormalities. Experimental models that perturb RS domain binding can help test this hypothesis.

Splicing regulators with RS domains are important for normal development and tissue-specific gene expression. When RS domain binding is disrupted, downstream splicing changes could affect neuronal and developmental programs. Although direct evidence for specific neurological diseases is still emerging, the mechanistic link between RS domain binding and splicing makes this function relevant to developmental and neurological research.

Recombinant RS domain fragments or synthetic RS peptides can be used in pull-down, ELISA, or surface plasmon resonance assays to measure direct binding. Phosphorylation of the RS domain can be mimicked or removed to test phospho-dependence. These assays provide quantitative binding parameters and help validate candidate interactions.

Proximity labeling enzymes fused to RS-domain proteins can identify nearby partners in living cells. Combined with mass spectrometry, this approach maps RS domain interaction networks and their changes upon perturbation. It is particularly useful for capturing weak or transient interactions that are characteristic of RS domain binding.

Fluorescence microscopy of tagged RS-domain proteins can reveal nuclear speckle association and subcellular localization. Live-cell imaging can track dynamic changes in speckle subcompartments and nucleocytoplasmic shuttling. These methods connect RS domain binding to higher-order nuclear organization.

CRISPR knockout, point mutation, and knock-in models allow causal testing of RS domain binding in cells. Library screening can identify genes that modify RS-domain-dependent phenotypes. Bioinformatics analysis of splicing and gene expression data then links molecular changes to cellular outcomes.

Researchers studying RS domain binding-related genes often need to determine whether a candidate gene is causally involved in a specific interaction, splicing event, or nuclear organization phenotype. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that make these causal tests possible.

GO:0050733 RS domain binding defines a phosphorylation-sensitive protein interaction that organizes splicing regulators and nuclear speckle subcompartments. Its study connects molecular recognition to splicing control, subcellular localization, and disease-relevant gene expression programs. By combining biochemical, imaging, and CRISPR-based approaches, researchers can move from correlation to causality and identify actionable nodes in RS-domain-dependent networks.